The National Taiwan University YongLin Institute of Health (NTU-YIH), established in September 2017, represents a significant milestone in Mr. Terry Gou's New Century Medical Initiative. Its primary mission is to advance research and development in the biomedical and health-related industries, promote the integration of interdisciplinary research resources, strengthen talent exchange and resource sharing within the industry, and foster the development of a biomedical technology cluster. The institute continuously introduces cutting-edge medical technologies and has appointed former National Taiwan University President Pan-Chyr Yang as its director.

YongLin Foundation collaborates with NTU to develop educational and industrial partnerships in the field of biomedical engineering, focusing on eight key areas: cell therapy, radiation medicine, smart hospitals, medical electronics, preventive medicine, biomarkers, biomedical talent cultivation, and future medicine. The Biomedical Hall is equipped with state-of-the-art infrastructure, including an optical fiber neural network system and a Big Data center. It is dedicated to the research and development of medical equipment and materials technology, advanced treatment devices, a stem cell transplantation center, and a preventive medicine center, among other collaborative efforts. Guided by the vision of "being rooted in Taiwan and looking toward the world," this initiative aspires to set a new milestone in biomedical engineering research.

By attracting internationally renowned scholars and nurturing a new generation of exceptional biomedical engineering talent in Taiwan, we aim to conduct long-term, in-depth research in the emerging fields of cancer medicine while fostering local development. This initiative seeks to position NTUCC as a leading global hub for cancer research, prevention, and treatment.

Since 2014, YongLin Foundation has partnered with NTU to invite internationally renowned biomedical engineering experts to form a research and industry team. This collaboration aims to pursue top-tier research spanning academia, technical development, and clinical applications, with the goal of achieving groundbreaking advancements in cancer medicine and related biomedical engineering fields, while also attracting exceptional talent.